Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.

BACKGROUND: Staphylococcus aureus bacteraemia is a common and serious infection, with an associated mortality of ~25%. Once in the blood, S. aureus can disseminate to infect almost any organ, but bones, joints and heart valves are most frequently affected. Despite the infection's severity, the...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Thwaites, G, Auckland, C, Barlow, G, Cunningham, R, Davies, G, Edgeworth, J, Greig, J, Hopkins, S, Jeyaratnam, D, Jenkins, N, Llewelyn, M, Meisner, S, Nsutebu, E, Planche, T, Read, R, Scarborough, M, Soares, M, Tilley, R, Török, M, Williams, J, Wilson, P, Wyllie, S, Walker, A
Format:	Journal article
Język:	English
Wydane:	2012

Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.

Podobne zapisy